Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
February 26, 2026
February 26, 2026
PHILADELPHIA, Pennsylvania, Feb. 26 [Category: Health Care] -- The Fox Chase Cancer Center, a part of Temple University Health System, posted the following news:
* * *
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
*
* The ctDNA blood test predicts metastatic risk, but not local recurrence, after bladder-sparing cancer treatment.
* Researchers said ctDNA could be used to help select patients likely to . . .
* * *
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
*
* The ctDNA blood test predicts metastatic risk, but not local recurrence, after bladder-sparing cancer treatment.
* Researchers said ctDNA could be used to help select patients likely to . . .